Related Experiment Video

Updated: Aug 31, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Myocardial perfusion imaging versus biochemical markers in acute coronary syndromes

D Vijay Anand1, A Lahiri

  • 1Department of Cardiac Research, Northwick Park Hospital, Harrow, UK.

Nuclear Medicine Communications
|September 26, 2003
PubMed

Insights

Diagnosing acute myocardial ischemia is challenging. Acute rest myocardial perfusion imaging offers immediate blood flow status, unlike cardiac troponins which take hours to become positive, aiding early triage decisions.

Area of Science:

  • Cardiology
  • Diagnostic Imaging

Background:

  • Acute chest pain with non-diagnostic ECGs presents a clinical management challenge.
  • Improving early diagnostic accuracy for acute myocardial ischemia is of significant interest.

Purpose of the Study:

  • To compare the utility of cardiac troponins and acute rest myocardial perfusion imaging in diagnosing acute myocardial infarction.
  • To evaluate strategies for improving early diagnostic accuracy in patients with possible acute myocardial ischemia.

Main Methods:

  • Comparison of sensitivities for detecting acute myocardial infarction between cardiac troponins (T and I) and acute rest myocardial perfusion imaging.
  • Analysis of the time course for marker positivity (cardiac troponins) versus immediate reflection of myocardial blood flow (perfusion imaging).

Main Results:

  • Cardiac troponins and acute rest myocardial perfusion imaging demonstrate similar sensitivities for acute myocardial infarction detection.
  • Cardiac troponins require 6-12 hours to become positive, while perfusion imaging provides immediate assessment of regional myocardial blood flow.

Conclusions:

  • Cardiac troponins are valuable for diagnosing myocardial injury, estimating its severity, and prognostication in high-risk patients.
  • Acute rest myocardial perfusion imaging is most appropriate for patients with acute ischemic symptoms, non-diagnostic ECGs, and low likelihood of necrosis, aiding triage.

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...